To further explore the roles of SPHK1 and HAS2 in pancreatic cancer, a preliminary analysis was performed to identify whether the expression of SPHK1 and HAS2 in pancreatic cancer tissues was associated with clinicopathological parameters. This evidence concerns the gene HAS2 and pancreatic neoplasm.